№ files_lp_4_process_2_71892
File format: docx
Character count: 4129
File size: 3835 KB
Year:
2026
Institution:
University of Latvia, Institute of Chemical Physics
Location:
Riga, Latvia
Authors:
Assoc. Prof. Elīna Pajuste, Mg. chem. Patrīcija Kalniņa, Mg. chem. Edgars Mamis
Type of document:
Research project description
Funding:
Latvian Council of Science, University of Latvia Foundation
Target radionuclides:
149Tb, 152Tb, 155Tb, Sc isotopes
Methods:
Mass separation, electrochemical and chemical purification, ion exchange resins, SEM, EDX, BET, FT-IR, pycnometry
Materials:
TaC, VC, VB, TiC-nanoscale, composite targets
Applications:
Theranostic radiopharmaceutical development, pre-clinical studies
Research facilities:
CERN-MEDICIS, University of Latvia radiochemistry lab
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Document type:
Supplementary material
Scientific field:
Molecular biology
Research focus:
Anticalin selection and affinity maturation
Target protein:
Membrane-bound Hsp70
Methodology:
Bacterial surface display
Techniques:
FACS screening, affinity maturation, directed evolution, SPR, CD spectroscopy, flow cytometry
Biological models:
E. coli, FaDu cells, OPM-2 cells
Authors:
Lars Friedrich; Petra Kornberger; Claudia T. Mendler; Gabriele Multhoff; Markus Schwaiger; Arne Skerra
Figures included:
Figures S1–S7
Related publication:
Main research article on Anticalin selection against Hsp70
Experimental scope:
In vitro binding analysis and cellular characterization
Event title:
Technical Training for PKI Operators for IMS Radionuclide and Waveform Stations
Dates:
3 to 5 March 2025
Venue:
Vienna International Centre
City:
Vienna
Country:
Austria
Organizing body:
CTBTO Preparatory Commission
Implementing section:
Capacity Building and Training Section (IDC/CBT)
Programme area:
International Monitoring System (IMS) and International Data Centre (IDC)
Type of document:
Registration form
Eligibility:
NDC staff, waveform analysts, radionuclide analysts, station operators, authorized IMS data and IDC product users
Submission deadline:
5 January 2025
Submission channel:
Permanent Mission in Vienna or Ministry of Foreign Affairs
Contact address:
P.O. Box 1200, A-1400 Vienna, Austria
Contact email:
[email protected]
Visa requirement:
Participants must obtain a visa to Austria upon receipt of an official Acceptance Note Verbale from the Provisional Technical Secretariat
Language requirement:
English proficiency indicated in reading, writing, speaking and understanding
Signatories:
Director of Institution; Candidate
Year:
2021
Region / City:
South Africa
Topic:
Nuclear Energy, Bidding Process, Radiopharmaceutical Equipment
Document Type:
Invitation to Bid
Organization / Institution:
South African Nuclear Energy Corporation (Necsa)
Author:
Not specified
Target Audience:
Bidders for the specified project
Validity Period:
90 Days
Approval Date:
Not specified
Amendment Date:
Not specified
Clarification Session Date:
17 January 2022
Closing Date:
08 February 2022
Closing Time:
11:00 am
Contact Person:
Mr. Buyani Nsibande
Contact Email:
[email protected]
Contact Phone:
+27 (0) 12 305 6072
Year:
2021
Region / city:
South Africa
Subject:
Nuclear energy, radiopharmaceuticals, medical technology
Document type:
Invitation to bid
Organization:
South African Nuclear Energy Corporation (Necsa)
Author:
South African Nuclear Energy Corporation (Necsa)
Target audience:
Bidders, suppliers, contractors
Period of validity:
90 Days (Commencing the bid Closing Date)
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2004
Region / City:
General Hospital
Topic:
Radiation Safety
Document Type:
Instruction Sheet
Organization / Institution:
General Hospital
Author:
Dr. John Smith
Target Audience:
Patients receiving radiopharmaceutical therapy
Action Period:
1 day - 26 days post-therapy
Approval Date:
January 1, 2004
Amendment Date:
N/A
Version:
Final Text
Date:
June 7, 2014
Note:
Developed pursuant to DICOM Work Item 2010-04-B
Annex A:
Registry of DICOM unique identifiers (UID)
Annex B:
DCMR Context Groups
Annex C:
Acquisition and Protocol Context Templates
Annex D:
DICOM Controlled Terminology Definitions
Annex J:
SNOMED DICOM Microglossary Retired Codes
Version:
Public Comment Letter Ballot
Send comments to:
[email protected]
Note:
November 4, 2013
Year:
2013
Region / City:
USA
Topic:
Radiopharmaceutical Radiation Dose Reporting
Document Type:
Supplement
Organization / Institution:
DICOM Standards Committee
Author:
DICOM Standards Committee
Target Audience:
Medical Imaging Professionals
Validity Period:
Not specified
Approval Date:
November 4, 2013
Amendment Date:
Not specified
Agency:
Department of Veterans Affairs
Contracting Office:
Network Contracting Office 9
Solicitation Number:
VA249-15-N-0558
Response Date:
June 26, 2015, 11:00 AM Central Time
Archive Days After Response Date:
90
NAICS Code:
325412
Classification Code:
65
Place of Performance:
Nashville, TN 37212
Contracting Office Address:
1639 Medical Center Parkway, Suite 400, Murfreesboro, TN 37129
Delivery Location:
Nuclear Medicine, Room D-40 and Room A-25, VA Tennessee Valley Healthcare System, 1310 24th Avenue South, Nashville, TN 37212
Point of Contact:
Stacey Lamb
Email:
[email protected]
Telephone (fax):
615-849-3714
Set-Aside Status:
To Be Determined Based on Market Research
Type of Notice:
Sources Sought Notice
Project Scope:
Daily provision and delivery of unit dose PET radiopharmaceuticals (FDG, N-13, Amyvid) Monday through Friday, including emergency and holiday services
Regulatory References:
FAR Part 6, FAR Part 10, FAR Part 19, FAR Clause 52.232-33
Registration Requirement:
System for Award Management (SAM)
Year:
2025
Region / City:
Not specified
Theme:
Pharmaceutical product information
Document type:
Product summary
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
FedBizOpps Sources Sought Notice for Radiopharmaceutical Supplies – Response Date September 08, 2014
Year:
2014
Response Date:
September 08, 2014, 10:00 AM EST
Solicitation Number:
VA246-14-I-0784
NAICS Code:
325412 (Pharmaceutical Manufacturing)
Agency:
Department of Veterans Affairs
Contracting Office:
Network Contracting Office 6
Place of Performance:
Charles George VAMC, Asheville, North Carolina, USA
Point of Contact:
Dwayne Tillery
Email:
[email protected]
Type of Notice:
Sources Sought Notice
Subject:
Radiopharmaceutical Supplies
Set-Aside:
N325412
Archive Days After Response Date:
60
Description:
Request for information to identify potential sources capable of providing specified radiopharmaceutical products and related items
Submission Requirements:
DUNS number, business size, socio-economic category, GSA or Federal Supply Schedule contract information (if available)
Recovery Act Funds:
Not indicated